Categories: Market News

J.M. Smucker (NYSE: SJM): Q3 2020 Earnings Snapshot

— The J.M. Smucker Company (NYSE: SJM) reported its third-quarter 2020 adjusted earnings of $2.35 per share versus $2.23 per share expected.

— Net sales declined by 2% to $1.97 billion, which is in-line with the analysts’ expectations. This was due to the reduced volume/mix in the US Retail Pet Foods segment, primarily driven by dog food.

— The net sales performance reflected strong growth for the Smucker’s Uncrustables brand and improved volume fundamentals for coffee and peanut butter brands, which supported market share and household penetration growth in both categories.

— The quarterly results were in-line with the company’s expectations, benefiting from continued investment in its strategic growth imperatives and the decisive actions it is taking to improve certain areas of the business.

— Sales from the US Retail Pet Foods declined by 5% due to volume/mix, which mostly related to the Natural Balance brand and private label dog food.

— For the full year 2020, net sales are still expected to be down 3% compared to the prior year. On a comparable basis, net sales are expected to be down 2%. The consensus estimates the top line to decline by 3.10%.

— Adjusted earnings per share are expected to be in the range of $8.10-8.30, based on 114.0 million shares outstanding, for the full year 2020. The consensus estimates EPS of $8.15.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

Share
Published by

Recent Posts

S&P Global (SPGI) reports double-digit growth in Q4 adj. earnings; revenue up 9%

S&P Global (NYSE: SPGI), a leading provider of financial intelligence solutions, reported strong earnings growth…

25 minutes ago

Fiserv (FISV) Earnings: 4Q25 Key Numbers

Fiserv Inc. (NASDAQ: FISV) reported its fourth quarter 2025 earnings results today. Revenue increased 1%…

38 minutes ago

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

40 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

1 hour ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

1 hour ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

1 hour ago